$1.43
2.72% yesterday
NYSE, Jun 13, 10:00 pm CET
ISIN
US7133171055
Symbol
PEPG
Sector
Industry

PepGen Stock price

$1.43
-0.10 6.54% 1M
-3.25 69.44% 6M
-2.36 62.27% YTD
-16.05 91.82% 1Y
-11.46 88.91% 5Y
-11.46 88.91% 10Y
-11.46 88.91% 20Y
NYSE, Closing price Fri, Jun 13 2025
-0.04 2.72%
ISIN
US7133171055
Symbol
PEPG
Sector
Industry

Key metrics

Market capitalization $46.79m
Enterprise Value $-50.99m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 0.61
P/B ratio (TTM) P/B ratio 0.51
Revenue (TTM) Revenue $0.00
EBIT (operating result TTM) EBIT $-109.26m
Free Cash Flow (TTM) Free Cash Flow $-83.34m
Cash position $97.78m
EPS (TTM) EPS $-3.14
P/E forward negative
Short interest 11.17%
Show more

Is PepGen a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,847 stocks worldwide.

PepGen Stock Analysis

Unlock Scores for Free

Analyst Opinions

5 Analysts have issued a PepGen forecast:

4x Buy
80%
1x Sell
20%

Analyst Opinions

5 Analysts have issued a PepGen forecast:

Buy
80%
Sell
20%

Financial data from PepGen

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 22 22
23% 23%
-
- Research and Development Expense 87 87
27% 27%
-
-108 -108
27% 27%
-
- Depreciation and Amortization 1.52 1.52
8% 8%
-
EBIT (Operating Income) EBIT -109 -109
26% 26%
-
Net Profit -102 -102
27% 27%
-

In millions USD.

Don't miss a Thing! We will send you all news about PepGen directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

PepGen Stock News

Neutral
Business Wire
one day ago
NEW YORK--(BUSINESS WIRE)---- $PEPG #ClassAction--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against PepGen Inc. (“PepGen” or the “Company”) (NASDAQ: PEPG) and reminds investors of the August 11, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a ...
Neutral
PRNewsWire
2 days ago
NEW YORK , June 12, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of PepGen Inc. (NASDAQ: PEPG). Shareholders who purchased shares of PEPG during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
Neutral
GlobeNewsWire
3 days ago
NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- June 11, 2025 - Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed on behalf of all investors who purchased or otherwise acquired securities of PepGen Inc. (NASDAQ: PEPG) between March 7, 2024 and March 3, 2025, inclusive (the “Class Period”).
More PepGen News

Company Profile

PepGen Inc. develops oligonucleotide therapies. It is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. The company was founded in March 26, 2018 and is headquartered in Boston, MA.

Head office United States
CEO James McArthur
Employees 72
Founded 2018
Website pepgen.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today